Dynatronics Corporation (DYNT)
USD 0.1
(0.0%)
USD 0.1
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -2.69 Million USD | 52.37% |
| 2023 | -5.66 Million USD | -19.84% |
| 2022 | -4.72 Million USD | -490.86% |
| 2021 | 1.2 Million USD | 128.01% |
| 2020 | -4.31 Million USD | -151.56% |
| 2019 | -1.71 Million USD | 50.96% |
| 2018 | -3.49 Million USD | 18.5% |
| 2017 | -4.29 Million USD | -88.75% |
| 2016 | -2.27 Million USD | 47.85% |
| 2015 | -4.36 Million USD | -1508.45% |
| 2014 | -271.14 Thousand USD | -511.08% |
| 2013 | -44.37 Thousand USD | -88.53% |
| 2012 | -23.53 Thousand USD | -108.69% |
| 2011 | 270.88 Thousand USD | -36.11% |
| 2010 | 423.97 Thousand USD | 310.34% |
| 2009 | 103.32 Thousand USD | 101.22% |
| 2008 | -8.44 Million USD | -9828.94% |
| 2007 | -85.04 Thousand USD | -143.83% |
| 2006 | 194.03 Thousand USD | -73.38% |
| 2005 | 728.81 Thousand USD | -17.49% |
| 2004 | 883.3 Thousand USD | 3461.84% |
| 2003 | 24.79 Thousand USD | -92.15% |
| 2002 | 316.1 Thousand USD | -5.41% |
| 2001 | 334.17 Thousand USD | 830.6% |
| 2000 | 35.91 Thousand USD | -94.87% |
| 1999 | 700 Thousand USD | 0.0% |
| 1998 | 700 Thousand USD | 16.67% |
| 1997 | 600 Thousand USD | 400.0% |
| 1996 | -200 Thousand USD | -200.0% |
| 1995 | 200 Thousand USD | -33.33% |
| 1994 | 300 Thousand USD | 0.0% |
| 1993 | 300 Thousand USD | 0.0% |
| 1992 | 300 Thousand USD | 0.0% |
| 1991 | 300 Thousand USD | -40.0% |
| 1990 | 500 Thousand USD | -28.57% |
| 1989 | 700 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -527.71 Thousand USD | 79.33% |
| 2024 Q3 | -851.39 Thousand USD | 29.21% |
| 2024 Q4 | -847 Thousand USD | 19.2% |
| 2024 Q2 | -1.2 Million USD | -127.9% |
| 2023 Q1 | -676.5 Thousand USD | 61.29% |
| 2023 FY | -4.97 Million USD | -54.01% |
| 2023 Q2 | -1.01 Million USD | -49.89% |
| 2023 Q3 | -1.42 Million USD | -40.08% |
| 2023 Q4 | -2.55 Million USD | -79.78% |
| 2022 FY | -3.22 Million USD | -261.35% |
| 2022 Q1 | 295.55 Thousand USD | -89.26% |
| 2022 Q2 | -1.62 Million USD | -649.27% |
| 2022 Q3 | -1.65 Million USD | -1.86% |
| 2022 Q4 | -1.74 Million USD | -5.69% |
| 2021 FY | 2 Million USD | 158.43% |
| 2021 Q1 | -571.93 Thousand USD | 76.9% |
| 2021 Q2 | -906.26 Thousand USD | -58.46% |
| 2021 Q3 | -63.66 Thousand USD | 92.97% |
| 2021 Q4 | 2.75 Million USD | 4421.02% |
| 2020 Q3 | -1.32 Million USD | -195.41% |
| 2020 Q1 | -68.06 Thousand USD | 84.58% |
| 2020 Q2 | -448.45 Thousand USD | -558.85% |
| 2020 FY | -3.42 Million USD | -271.88% |
| 2020 Q4 | -2.47 Million USD | -86.87% |
| 2019 Q3 | -759.62 Thousand USD | -17.94% |
| 2019 Q4 | -441.31 Thousand USD | 41.9% |
| 2019 FY | -921 Thousand USD | 42.52% |
| 2019 Q1 | 128.96 Thousand USD | 117.72% |
| 2019 Q2 | -644.09 Thousand USD | -599.44% |
| 2018 Q3 | -1.46 Million USD | -11.64% |
| 2018 Q4 | -727.71 Thousand USD | 50.43% |
| 2018 FY | -1.6 Million USD | 14.15% |
| 2018 Q1 | 11.58 Thousand USD | 100.46% |
| 2018 Q2 | -1.31 Million USD | -11449.18% |
| 2017 FY | -1.86 Million USD | 1.89% |
| 2017 Q4 | -2.5 Million USD | -195.72% |
| 2017 Q3 | -848.71 Thousand USD | -51.56% |
| 2017 Q1 | -374.61 Thousand USD | 70.64% |
| 2017 Q2 | -559.96 Thousand USD | -49.48% |
| 2016 FY | -1.9 Million USD | 15.47% |
| 2016 Q4 | -1.27 Million USD | -140.24% |
| 2016 Q3 | -531.18 Thousand USD | -158.89% |
| 2016 Q2 | -205.18 Thousand USD | 21.71% |
| 2016 Q1 | -262.06 Thousand USD | 93.55% |
| 2015 Q3 | -208.01 Thousand USD | -55.76% |
| 2015 FY | -2.25 Million USD | -729.95% |
| 2015 Q1 | 40.92 Thousand USD | 189.55% |
| 2015 Q2 | -133.54 Thousand USD | -426.33% |
| 2015 Q4 | -4.06 Million USD | -1852.07% |
| 2014 Q3 | -161.75 Thousand USD | -466.83% |
| 2014 FY | -271.14 Thousand USD | -511.08% |
| 2014 Q4 | -45.7 Thousand USD | 71.75% |
| 2014 Q1 | -107.78 Thousand USD | -47.47% |
| 2014 Q2 | 44.09 Thousand USD | 140.91% |
| 2013 FY | -44.37 Thousand USD | -88.53% |
| 2013 Q4 | -73.08 Thousand USD | -19.58% |
| 2013 Q3 | -61.12 Thousand USD | -143.35% |
| 2013 Q2 | 140.98 Thousand USD | 375.65% |
| 2013 Q1 | -51.14 Thousand USD | -144.11% |
| 2012 Q3 | -117.56 Thousand USD | -353.73% |
| 2012 Q4 | 115.95 Thousand USD | 198.63% |
| 2012 FY | -23.53 Thousand USD | -108.69% |
| 2012 Q1 | -68.25 Thousand USD | -199.25% |
| 2012 Q2 | 46.33 Thousand USD | 167.88% |
| 2011 Q1 | 17.01 Thousand USD | -76.02% |
| 2011 Q2 | 67.83 Thousand USD | 298.77% |
| 2011 Q4 | 68.77 Thousand USD | -41.35% |
| 2011 Q3 | 117.26 Thousand USD | 72.85% |
| 2011 FY | 270.88 Thousand USD | -36.11% |
| 2010 Q1 | 68.62 Thousand USD | 48.86% |
| 2010 Q3 | 96.09 Thousand USD | -48.96% |
| 2010 Q4 | 70.95 Thousand USD | -26.16% |
| 2010 Q2 | 188.29 Thousand USD | 174.39% |
| 2010 FY | 423.97 Thousand USD | 310.34% |
| 2009 Q3 | 141.57 Thousand USD | 159.31% |
| 2009 Q1 | -138.95 Thousand USD | 97.95% |
| 2009 Q2 | 54.59 Thousand USD | 139.29% |
| 2009 FY | 103.32 Thousand USD | 101.22% |
| 2009 Q4 | 46.1 Thousand USD | -67.44% |
| 2008 Q1 | -712.2 Thousand USD | -431.35% |
| 2008 Q2 | -338.79 Thousand USD | 52.43% |
| 2008 Q3 | -628.77 Thousand USD | -85.59% |
| 2008 Q4 | -6.76 Million USD | -975.74% |
| 2008 FY | -8.44 Million USD | -9828.94% |
| 2007 FY | -85.04 Thousand USD | -143.83% |
| 2007 Q3 | -81.38 Thousand USD | -86.73% |
| 2007 Q1 | -175 Thousand USD | -547.59% |
| 2007 Q2 | -43.58 Thousand USD | 75.09% |
| 2007 Q4 | 214.94 Thousand USD | 364.09% |
| 2006 FY | 194.03 Thousand USD | -73.38% |
| 2006 Q4 | 39.1 Thousand USD | 129.74% |
| 2006 Q3 | 17.01 Thousand USD | -89.38% |
| 2006 Q2 | 160.23 Thousand USD | 817.86% |
| 2006 Q1 | -22.32 Thousand USD | -113.16% |
| 2005 Q4 | 169.59 Thousand USD | 2.94% |
| 2005 Q3 | 164.76 Thousand USD | -32.78% |
| 2005 FY | 728.81 Thousand USD | -17.49% |
| 2005 Q1 | 149.34 Thousand USD | -5.62% |
| 2005 Q2 | 245.1 Thousand USD | 64.12% |
| 2004 Q4 | 158.24 Thousand USD | -48.91% |
| 2004 Q2 | 254.78 Thousand USD | 58.67% |
| 2004 Q3 | 309.7 Thousand USD | 21.55% |
| 2004 FY | 883.3 Thousand USD | 3461.84% |
| 2004 Q1 | 160.57 Thousand USD | 202.78% |
| 2003 FY | 24.79 Thousand USD | -92.15% |
| 2003 Q2 | 49.5 Thousand USD | -54.27% |
| 2003 Q1 | 108.26 Thousand USD | 20.54% |
| 2003 Q4 | -156.22 Thousand USD | -771.85% |
| 2003 Q3 | 23.25 Thousand USD | -53.03% |
| 2002 Q3 | 82.92 Thousand USD | 78.25% |
| 2002 FY | 316.1 Thousand USD | -5.41% |
| 2002 Q4 | 89.81 Thousand USD | 8.31% |
| 2002 Q2 | 46.52 Thousand USD | -51.96% |
| 2002 Q1 | 96.84 Thousand USD | 24.97% |
| 2001 Q2 | 45.72 Thousand USD | -61.88% |
| 2001 Q3 | 91.01 Thousand USD | 99.04% |
| 2001 Q4 | 77.49 Thousand USD | -14.86% |
| 2001 FY | 334.17 Thousand USD | 830.6% |
| 2001 Q1 | 119.95 Thousand USD | -55.43% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q3 | -197.56 Thousand USD | 0.0% |
| 2000 FY | 35.91 Thousand USD | -94.87% |
| 2000 Q1 | - USD | 0.0% |
| 2000 Q4 | 269.15 Thousand USD | 236.24% |
| 1999 Q2 | 200 Thousand USD | -50.0% |
| 1999 Q4 | - USD | -100.0% |
| 1999 FY | 700 Thousand USD | 0.0% |
| 1999 Q1 | 400 Thousand USD | 300.0% |
| 1999 Q3 | 100 Thousand USD | -50.0% |
| 1998 Q3 | 200 Thousand USD | 100.0% |
| 1998 FY | 700 Thousand USD | 16.67% |
| 1998 Q1 | 200 Thousand USD | 0.0% |
| 1998 Q2 | 100 Thousand USD | -50.0% |
| 1998 Q4 | 100 Thousand USD | -50.0% |
| 1997 Q4 | 200 Thousand USD | -33.33% |
| 1997 Q3 | 300 Thousand USD | 200.0% |
| 1997 Q1 | 100 Thousand USD | 125.0% |
| 1997 Q2 | 100 Thousand USD | 0.0% |
| 1997 FY | 600 Thousand USD | 400.0% |
| 1996 FY | -200 Thousand USD | -200.0% |
| 1996 Q4 | -400 Thousand USD | -500.0% |
| 1996 Q3 | 100 Thousand USD | 0.0% |
| 1996 Q2 | 100 Thousand USD | 0.0% |
| 1996 Q1 | - USD | 0.0% |
| 1995 FY | 200 Thousand USD | -33.33% |
| 1995 Q3 | - USD | -100.0% |
| 1995 Q2 | 100 Thousand USD | 0.0% |
| 1995 Q1 | 100 Thousand USD | 200.0% |
| 1995 Q4 | - USD | 0.0% |
| 1994 Q2 | - USD | -100.0% |
| 1994 Q1 | 300 Thousand USD | 50.0% |
| 1994 FY | 300 Thousand USD | 0.0% |
| 1994 Q4 | -100 Thousand USD | 0.0% |
| 1994 Q3 | - USD | 0.0% |
| 1993 Q4 | 200 Thousand USD | 100.0% |
| 1993 Q1 | - USD | 0.0% |
| 1993 FY | 300 Thousand USD | 0.0% |
| 1993 Q2 | - USD | 0.0% |
| 1993 Q3 | 100 Thousand USD | 0.0% |
| 1992 Q3 | 100 Thousand USD | 0.0% |
| 1992 Q2 | 100 Thousand USD | 0.0% |
| 1992 Q1 | 100 Thousand USD | 0.0% |
| 1992 Q4 | - USD | -100.0% |
| 1992 FY | 300 Thousand USD | 0.0% |
| 1991 Q2 | - USD | -100.0% |
| 1991 Q1 | 100 Thousand USD | -50.0% |
| 1991 Q4 | 100 Thousand USD | 0.0% |
| 1991 Q3 | 100 Thousand USD | 0.0% |
| 1991 FY | 300 Thousand USD | -40.0% |
| 1990 Q2 | - USD | 0.0% |
| 1990 Q4 | 200 Thousand USD | 100.0% |
| 1990 FY | 500 Thousand USD | -28.57% |
| 1990 Q1 | - USD | 0.0% |
| 1990 Q3 | 100 Thousand USD | 0.0% |
| 1989 Q1 | - USD | 0.0% |
| 1989 Q2 | - USD | 0.0% |
| 1989 FY | 700 Thousand USD | 0.0% |
| 1989 Q4 | - USD | 0.0% |
| 1989 Q3 | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -81.66 Million USD | 96.697% |
| Cerus Corporation | -37.48 Million USD | 92.804% |
| OrthoPediatrics Corp. | -20.97 Million USD | 87.138% |
| PetVivo Holdings, Inc. | -10.95 Million USD | 75.375% |
| Talis Biomedical Corporation | -62 Million USD | 95.649% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | 80.139% |
| Inogen, Inc. | -102.44 Million USD | 97.367% |
| Spectral AI, Inc. | -20.85 Million USD | 87.064% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 95.561% |
| CVRx, Inc. | -41.19 Million USD | 93.452% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 521.39% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | 69.517% |
| Orthofix Medical Inc. | -151.39 Million USD | 98.218% |
| Venus Concept Inc. | -37.25 Million USD | 92.758% |
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 95.622% |
| Bioventus Inc. | -156.23 Million USD | 98.273% |
| BrainsWay Ltd. | -4.19 Million USD | 35.723% |
| Envoy Medical, Inc. | -29.9 Million USD | 90.98% |
| electroCore, Inc. | -18.83 Million USD | 85.676% |
| IceCure Medical Ltd | -14.65 Million USD | 81.588% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 94.878% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | 80.373% |
| MaxCyte, Inc. | -37.92 Million USD | 92.886% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | 77.253% |
| Nexalin Technology, Inc. | -4.64 Million USD | 41.968% |
| PAVmed Inc | -64.17 Million USD | 95.796% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 94.858% |
| RxSight, Inc. | -48.6 Million USD | 94.45% |
| Sight Sciences, Inc. | -55.54 Million USD | 95.143% |
| SI-BONE, Inc. | -43.33 Million USD | 93.775% |
| TELA Bio, Inc. | -46.66 Million USD | 94.219% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 95.431% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 94.553% |
| LivaNova PLC | 17.54 Million USD | 115.375% |
| 908 Devices Inc. | -36.39 Million USD | 92.588% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 98.555% |
| Nemaura Medical Inc. | -14.14 Million USD | 80.926% |
| NeuroPace, Inc. | -32.95 Million USD | 91.814% |
| LENSAR, Inc. | -14.38 Million USD | 81.244% |
| Apyx Medical Corporation | -18.71 Million USD | 85.584% |
| Cutera, Inc. | -162.83 Million USD | 98.343% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | 75.09% |
| BioSig Technologies, Inc. | -29.04 Million USD | 90.711% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 96.737% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 87.787% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 103.982% |
| Axonics, Inc. | -6.08 Million USD | 55.688% |
| Outset Medical, Inc. | -172.79 Million USD | 98.439% |
| IRIDEX Corporation | -9.57 Million USD | 71.811% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 97.453% |
| IRadimed Corporation | 17.19 Million USD | 115.691% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 67.277% |
| INVO Bioscience, Inc. | -8.03 Million USD | 66.424% |
| Telesis Bio, Inc. | -47.72 Million USD | 94.347% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 126.337% |
| Varex Imaging Corporation | -47.7 Million USD | 94.344% |
| Quipt Home Medical Corp. | -2.78 Million USD | 3.099% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 76.097% |
| Pulmonx Corporation | -60.84 Million USD | 95.566% |
| Modular Medical, Inc. | -17.47 Million USD | 84.558% |
| ReShape Lifesciences Inc. | -11.38 Million USD | 76.309% |
| Semler Scientific, Inc. | 20.58 Million USD | 113.107% |
| InMode Ltd. | 197.91 Million USD | 101.363% |
| Bruker Corporation | 427.2 Million USD | 100.631% |
| Cytosorbents Corporation | -28.5 Million USD | 90.537% |
| DexCom, Inc. | 541.5 Million USD | 100.498% |
| Align Technology, Inc. | 445.05 Million USD | 100.606% |
| Viveve Medical, Inc. | -22.02 Million USD | 87.753% |
| ZimVie Inc. | -393.28 Million USD | 99.314% |
| Movano Inc. | -29.28 Million USD | 90.787% |
| Cytek Biosciences, Inc. | -12.14 Million USD | 77.793% |
| Nexalin Technology, Inc. | -4.64 Million USD | 41.968% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 521.39% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 98.788% |
| Profound Medical Corp. | -28.56 Million USD | 90.557% |
| Insulet Corporation | 206.3 Million USD | 101.308% |
| enVVeno Medical Corporation | -23.51 Million USD | 88.528% |
| Surmodics, Inc. | -11.54 Million USD | 76.627% |
| iCAD, Inc. | -4.84 Million USD | 44.343% |
| Nuwellis, Inc. | -20.2 Million USD | 86.651% |
| Biotricity, Inc. | -14.09 Million USD | 80.859% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 97.814% |
| Aethlon Medical, Inc. | -12.2 Million USD | 77.902% |
| InspireMD, Inc. | -19.91 Million USD | 86.455% |
| PAVmed Inc. | -64.17 Million USD | 95.796% |
| BIOLASE, Inc. | -20.63 Million USD | 86.925% |
| Beyond Air, Inc. | -60.24 Million USD | 95.522% |
| FONAR Corporation | 10.56 Million USD | 125.529% |
| AxoGen, Inc. | -21.71 Million USD | 87.577% |
| Vivani Medical, Inc. | -25.65 Million USD | 89.483% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 109.461% |
| Inari Medical, Inc. | -1.63 Million USD | -64.897% |
| UFP Technologies, Inc. | 44.92 Million USD | 106.005% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | 47.437% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | 59.158% |
| Tenon Medical, Inc. | -15.58 Million USD | 82.686% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 82.512% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 92.365% |
| AdaptHealth Corp. | -678.89 Million USD | 99.603% |
| Sintx Technologies, Inc. | -8.25 Million USD | 67.336% |
| NanoVibronix, Inc. | -3.71 Million USD | 27.305% |
| Quanterix Corporation | -32.33 Million USD | 91.657% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 76.097% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 656.231% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 99.121% |
| TransMedics Group, Inc. | -25.02 Million USD | 89.221% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 87.811% |
| NeuroMetrix, Inc. | -6.52 Million USD | 58.684% |
| Hyperfine, Inc. | -44.23 Million USD | 93.902% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 96.564% |
| Biomerica, Inc. | -5.97 Million USD | 54.873% |
| Bone Biologics Corporation | -8.94 Million USD | 69.854% |
| AVITA Medical, Inc. | -39.16 Million USD | 93.112% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | 72.898% |
| Silk Road Medical, Inc | -55.74 Million USD | 95.16% |